Pharmaniaga Berhad Balance Sheet

Financials in millions MYR. Fiscal year is January - December.

Millions MYR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	54.3	68.68	114.74	52.85	47.11
Short-Term Investments	223.27	67.36	2.87	4.11	10.25
Cash & Short-Term Investments	277.57	136.04	117.61	56.96	57.36
Cash Growth	104.04%	15.67%	106.48%	-0.70%	40.85%
Accounts Receivable	324.55	337.63	285.22	261.75	227.85
Other Receivables	97.52	86.98	84.4	76.77	44.1
Receivables	422.06	424.6	369.62	338.52	271.95
Inventory	729.82	612.79	580.64	767.26	1,264
Prepaid Expenses	16.49	11.06	26.9	32.06	27.52
Restricted Cash	18.3	19.8	12.7	-	-
Total Current Assets	1,464	1,204	1,107	1,195	1,621
Property, Plant & Equipment	602.78	609.36	605.75	443.03	395.59
Goodwill	77.03	77.31	77.47	77.34	129.48
Other Intangible Assets	22.65	28.25	23.8	72.39	75.31
Long-Term Deferred Tax Assets	28.15	27.34	52.08	48.89	33.07
Long-Term Deferred Charges	51.97	45.76	48.3	10.83	3.23
Total Assets	2,247	1,992	1,915	1,847	2,258
Accounts Payable	776.48	650.1	627.78	648.02	677.63
Accrued Expenses	40.47	96.19	91.6	46.78	31.53
Short-Term Debt	527.49	771.26	711.18	681.3	543.98
Current Portion of Long-Term Debt	162.55	283.41	335.87	384.45	25.7
Current Portion of Leases	3.99	4.48	4.62	5.67	1.57
Current Income Taxes Payable	6.97	10.46	9.8	4.27	14.44
Current Unearned Revenue	11.69	29.76	9.16	31.28	22.46
Other Current Liabilities	81.45	107.43	212.44	265.93	150.46
Total Current Liabilities	1,611	1,953	2,002	2,068	1,468
Long-Term Debt	125.4	129.57	138.62	91.67	284.99
Long-Term Leases	0.37	3.18	1.09	5	0.62
Long-Term Unearned Revenue	15.22	14.51	3.1	3.36	3.62
Pension & Post-Retirement Benefits	10.56	10.79	10.84	9.05	9.08
Long-Term Deferred Tax Liabilities	25.05	27.13	32.85	18.82	21.35
Total Liabilities	1,788	2,138	2,189	2,196	1,787
Common Stock	243.43	200.05	200.05	154.19	154.05
Retained Earnings	97.06	-471.41	-603.42	-525.23	293.73
Comprehensive Income & Other	93.98	100.09	104.31	1.34	2.69
Total Common Equity	434.47	-171.28	-299.07	-369.69	450.46
Minority Interest	24.69	25.33	24.98	21.39	19.98
Shareholders' Equity	459.16	-145.94	-274.09	-348.31	470.44
Total Liabilities & Equity	2,247	1,992	1,915	1,847	2,258
Total Debt	819.79	1,192	1,191	1,168	856.86
Net Cash (Debt)	-542.22	-1,056	-1,074	-1,111	-799.5
Net Cash Per Share	-0.15	-0.73	-0.79	-0.85	-0.61
Filing Date Shares Outstanding	6,557	1,441	1,441	1,310	1,310
Total Common Shares Outstanding	6,557	1,441	1,441	1,310	1,310
Working Capital	-146.85	-748.78	-894.98	-872.9	153.43
Book Value Per Share	0.07	-0.12	-0.21	-0.28	0.34
Tangible Book Value	334.79	-276.83	-400.33	-519.43	245.68
Tangible Book Value Per Share	0.05	-0.19	-0.28	-0.40	0.19
Land	394.94	393.11	394.01	25.66	25.55
Buildings	-	-	-	254.02	255.22
Machinery	503.78	503.2	497.02	444.29	430.76
Construction In Progress	142.41	125.81	109.28	75.42	30.17

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.